➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Dow
Boehringer Ingelheim
Colorcon
McKesson
Express Scripts

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Trehalose


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Trehalose?

Trehalose is an investigational drug.

There have been 11 clinical trials for Trehalose. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2021.

The most common disease conditions in clinical trials are Macular Edema, Bipolar Disorder, and Fatty Liver. The leading clinical trial sponsors are Bioblast Pharma Ltd., Mashhad University of Medical Sciences, and Soll Eye.

There is one US patent protecting this investigational drug and thirty-six international patents.

Recent Clinical Trials for Trehalose
TitleSponsorPhase
Phase IV Study to Evaluate the Efficacy of LagricelĀ® Ofteno PF Compared to ThealozĀ® Duo After Photorefractive Keratectomy (PRK)Laboratorios Sophia S.A de C.V.Phase 4
Phenylbutyrate for STXBP1 EncephalopathyWeill Medical College of Cornell UniversityEarly Phase 1
Mycose AdminiStration for HealIng Alzheimer NEuropathy (MASHIANE)Mashhad University of Medical SciencesPhase 1

See all Trehalose clinical trials

Clinical Trial Summary for Trehalose

Top disease conditions for Trehalose
Top clinical trial sponsors for Trehalose

See all Trehalose clinical trials

US Patents for Trehalose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Trehalose ⤷  Free Forever Trial Compounds alpha v beta 6 integrin antagonists GlaxoSmithKline Intellectual Property Development Limited (Brentford, Middlesex, GB) ⤷  Free Forever Trial
Trehalose ⤷  Free Forever Trial Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof Shionogi & Co., Ltd. (Osaka, JP) ⤷  Free Forever Trial
Trehalose ⤷  Free Forever Trial Method of reducing blood glucose by administering RON agonists GENENTECH, INC. (South San Francisco, CA) ⤷  Free Forever Trial
Trehalose ⤷  Free Forever Trial Substituted pyridazines for the treatment of pain INHIBITAXIN LIMITED (Sandwich Kent, GB) ⤷  Free Forever Trial
Trehalose ⤷  Free Forever Trial Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Crestovo Holdings LLC (Somerville, MA) ⤷  Free Forever Trial
Trehalose ⤷  Free Forever Trial Methods for treating spinal cord injury MASSACHUSETTS EYE AND EAR INFIRMARY (Boston, MA) CHILDREN'S MEDICAL CENTER CORPORATION (Boston, MA) ⤷  Free Forever Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Trehalose

Drugname Country Document Number Estimated Expiration Related US Patent
Trehalose Australia AU2015320874 2034-09-26 ⤷  Free Forever Trial
Trehalose Brazil BR112017006240 2034-09-26 ⤷  Free Forever Trial
Trehalose Canada CA2962319 2034-09-26 ⤷  Free Forever Trial
Trehalose China CN107074850 2034-09-26 ⤷  Free Forever Trial
Trehalose European Patent Office EP3197895 2034-09-26 ⤷  Free Forever Trial
Trehalose Spain ES2796235 2034-09-26 ⤷  Free Forever Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Boehringer Ingelheim
AstraZeneca
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.